\[
\large\mathcal{YiHsin}\;\mathcal{Sam}\;\mathcal{Lu}
\]
【Summary】 Patients increasing:
- Increasing “all levels” (e.g. Gender)
- Increasing “one level” (e.g. Cell type)
- “Yes>No” to “No>Yes” (e.g. Mortality)
- Total: 4682
1 Variables
ECOG
- 0 無症狀
- 1 有症狀,可步行對生活不影響
- 2 躺在床上時間小於50%
- 3 躺在床上時間大於50%
- 4 完全臥床
BMI
- 1 Normal: \(\leq25\)
- Overweight: \(>25\)
Cell Type
- 1 Urothelial
- 2 Squamous
- 3 Small cell
- 4 Adenocarcinoma
- 5 UC with variants (Squamous cell, glandular, sarcomatous, micro
papillary, neuroendocrine, lymphoepithelial)
- 6 Others
Location
- 0 Non-visible
- 1 Renal pelvis (“1 腎盂”)
- 2 Ureter (“2 上輸尿管”、“3 中輸尿管”、“4 下輸尿管”、“6 Ureter,
unknown site”)
- 3 Bladder cuff (“5 膀胱袖口”)
- 4 Multiple locations (多選)
Size
- 1 \(<2\) cm (“0 Non-visible”, “1
\(<1\) cm” and “\(\geq1\) & \(<2\) cm”)
- 2 \(\geq2\) cm (“3 \(\geq2\) & \(<3\) cm” and “4 \(\geq3\) cm”) ****
Biopsy Method
- 0 Not perform Biopsy
- 1 URS/ flexible URS Biopsy
- 2 CT/ Ultrasound guide Biopsy
- 3 PCN biopsy
- 5 URS/CT (“1 URS/ flexible URS Biopsy” and “2 CT/ Ultrasound guide
Biopsy”)
Pre-operative Hydronephrosis
Chemotherapy Type (UTUC)
- 5 Salvage or Palliative (“3 Salvage” and “4 Palliative”)
Chemotherapy Prescription (UTUC)
Radiation Therapy Type
- 5 Salvage or Palliative (“3 Salvage” and “4 Palliative”)
Simultaneously Ipsilateral Adrenalectomy
Post_operation Intravesical C/T Instillation
- 1 Intraprocedural intravesical therapy (“術中膀胱灌藥”)
- 2 Post-operative intravesical therapy (“術後膀胱灌藥”)
2 Outcomes
Clavien Dindo Classification
3 Comparison
pT Stage vs Surgery Method
Surgery Method vs Neo-Adjuvant
Surgery Method vs Surgical Margin
Chemotherapy Type vs Bladder Free